fig2

Figure 2. Overall survival from BVZ administration calculated by Kaplan-Meier curves for 31 patients stratified by: (A) NLR positive or negative; (B) PLR positive or negative; (C) Association between NLR and PLR. It seems the more NLR increases, the more PLR increases as well. This association is almost statistically significant following a Spearman test (P > 0.05; 95%CI). BVZ: bevacizumab; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio